Participating urologists
postbiopsy
A total of 10 urologists participated in the study. At Visit 1, coordinators ascertained the urologists' initial treatment preference prior to evaluating the patient. The only information presented at the time was the patient's name, age, PSA, clinical stage/digital rectal exam results, and their NCCN risk group. Responses were documented using a standardized survey, which allowed urologists to choose from several treatment modalities: AS, radiotherapy, radical prostatectomy, and other. A second survey was obtained prior to the patient's second postbiopsy visit (Visit 2). Urologist would receive the patient's name, NCCN risk group, and GPS report (if randomized to Intervention arm). The urologists' treatment preference recorded at Visit 2 is the primary outcome of this study.